Increased levels of ABCA7 expression were described in AD patients and were also positively correlated with cognitive decline.198,211 This finding is consistent with Abca7 mRNA transcription levels in J20 mice.123 The increase of ABCA7 may be a compensatory defense mechanism that is insufficient to stop disease progression. Here, ABCA7 is linked to Alzheimer disease.